BlackRock’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,169,751
| Closed | -$64.3M | – | 5934 |
|
|
2022
Q2 | $64.3M | Buy |
1,169,751
+721,321
| +161% | +$39.7M | ﹤0.01% | 2293 |
|
|
2022
Q1 | $14.4M | Buy |
448,430
+424,985
| +1,813% | +$13.6M | ﹤0.01% | 3304 |
|
|
2021
Q4 | $509K | Buy |
23,445
+2,988
| +15% | +$64.9K | ﹤0.01% | 4795 |
|
|
2021
Q3 | $448K | Sell |
20,457
-1,031
| -5% | -$22.6K | ﹤0.01% | 4719 |
|
|
2021
Q2 | $419K | Buy |
21,488
+17,303
| +413% | +$337K | ﹤0.01% | 4664 |
|
|
2021
Q1 | $72K | Buy |
4,185
+2,429
| +138% | +$41.8K | ﹤0.01% | 4811 |
|
|
2020
Q4 | $28K | Sell |
1,756
-2,684
| -60% | -$42.8K | ﹤0.01% | 4665 |
|
|
2020
Q3 | $47K | Buy |
4,440
+435
| +11% | +$4.61K | ﹤0.01% | 4519 |
|
|
2020
Q2 | $48K | Buy |
+4,005
| New | +$48K | ﹤0.01% | 4504 |
|
|
2018
Q3 | – | Sell |
-144
| Closed | -$17K | – | 5029 |
|
|
2018
Q2 | $17K | Buy |
+144
| New | +$17K | ﹤0.01% | 4645 |
|